Attempts at treatment of intracranial arterial spasm in animals and human beings.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D002339:Carotid Arteries / Q000000981:diagnostic imaging; D002533:Cerebral Angiography; D002539:Cerebral Arterial Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013035:Spasm / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D013345:Subarachnoid Hemorrhage / Q000150:complications; D013565:Sympatholytics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000933:Antifibrinolytic Agents; D013565:Sympatholytics; D014665:Vasodilator Agents